BeiGene (HKG:6160, SHA:688235) reported that its net loss for 2024 narrowed by 26.9% to $644.8 million from the $881.7 million loss a year earlier, according to a Thursday filing with the Hong Kong bourse.
Loss per share narrowed 27.7% to $0.47 from $0.65 loss per share a year ago.
Revenue rose 55.0% to $3.78 billion from $2.19 billion the previous year.
The company's shares were up 1% at the Hong Kong bourse while down less than 1% at the Shanghai bourse in recent trading.